IRB Updates

  • We updated out COVID-19 guidance to include links to FDA guidance re: acceptable consent methods for participants in isolation. We also made various minor updates throughout.
  • Important updated External IRB guidelines on what to submit to Emory IRB at time of continuing review and after major reportable events.
  • Guidelines to avoid delay when submitting study Modifications that indicate a new or increased risk

If you have any questions or suggestions, please reach us at   We also have a page dedicated to COVID-19 resources.


This entry was posted in IRB and tagged , , , . Bookmark the permalink. Both comments and trackbacks are currently closed.